SCHEMBL855644

SCHEMBL855644

CS(=O)(=O)Nc1cccc(-c2ccc3[nH]cc(C(=O)c4cc(Cl)cc(Cl)c4)c3c2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 3/20 0.45
AAK1 Q2M2I8 1/20 0.44
CYP1A2 P05177 5/20 0.43
CYP3A4 P08684 5/20 0.43
CYP2C19 P33261 4/20 0.43
CYP2D6 P10635 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
HPGD P15428 1/20 0.43
NHERF1 O14745 2/20 0.42
CYP2C9 P11712 1/20 0.41
HSD17B1 P14061 1/20 0.41
HSD17B2 P37059 1/20 0.41
HSD17B3 P37058 1/20 0.41
KIF11 P52732 1/20 0.41
USP2 O75604 3/20 0.40
LMNA P02545 3/20 0.40
CLK4 Q9HAZ1 3/20 0.40
ALDH1A1 P00352 2/20 0.40
MAPK1 P28482 2/20 0.40
TSHR P16473 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL414867 0.85 TNIK (0.53) AAK1CYP2C19CYP2C9BTK
SCHEMBL17854948 0.78 AAK1 (0.43) NR4A2AAK1CYP1A2CYP3A4CYP2C19
SCHEMBL857599 0.77 BRAF (0.54) AAK1CYP2C19CYP2C9BTKCAMKK2
SCHEMBL878650 0.74 TNIK (0.54) AAK1CYP1A2CYP3A4CYP2C19CYP2D6
SCHEMBL416872 0.72 TNIK (0.56) AAK1CYP2D6
SCHEMBL878738 0.71 TNIK (0.55) AAK1CYP2C19CYP2C9HSD17B1HSD17B2
SCHEMBL413343 0.71 NTRK1 (0.60) AAK1BTK
SCHEMBL3706659 0.71 INSR (0.55) AAK1CYP2C19CYP2C9CLK4MAPK1
SCHEMBL298800 0.71 TNIK (0.54) AAK1CYP2C19CYP2C9BTKCAMKK2
SCHEMBL3244339 0.70 BRD4 (0.42) NR4A2AAK1CYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143271-B2 Compounds and methods for kinase modulation, and indications therefor PLEXXIKON INC. (US) 2012-03-27 US disclosed
US-8143271-B2 Compounds and methods for kinase modulation, and indications therefor PLEXXIKON INC. (US) 2012-03-27 US disclosed